Skip to content

    Summit Therapeutics (SMMT) financials

    View SMMT earnings calls

    Price

    Market Cap

    Sector

    Rank

    Performance9.8% 1Y

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    Operating Profit
    -$58.38M
    -$65.61M
    Net Profit
    -$56.25M
    -$61.20M
    -$62.91M
    -$565.71M
    -$231.79M
    -312.0%
    -$219.17M
    -258.1%
    -$189.42M
    -201.1%
    -$215.70M
    +61.9%
    Weakening
    EPS
    $-0.08
    $-0.09
    $-0.76
    $-0.31
    -287.5%
    $-0.24
    -166.7%
    $-0.28
    +63.2%
    Weakening
    Other Income
    $4.58M
    $4.42M
    $3.94M
    $2.73M
    $2.42M
    -47.2%
    $5.75M
    +30.2%
    $5.79M
    +47.0%
    $4.80M
    +75.7%
    Strengthening
    Interest
    $2.45M
    $9.0K
    $0
    $0
    $0
    -100.0%
    $0
    -100.0%
    Weakening
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    2.1%
    2.3%
    2.3%
    21.0%
    8.6%
    +312.0%
    8.1%
    +258.1%
    7.0%
    +201.1%
    8.0%
    -61.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$35.24M$63.84M$66.42M$71.79M$348.61M$71.42M$104.86M$225.27M$419.37M
    Short-Term Investments
    Total Current Assets$79.63M$87.67M$97.31M$656.71M$189.71M$423.75M$720.30M$720.58M
    Net PP&E$1.54M$1.28M$3.48M$5.08M$6.06M$7.40M$21.68M$21.19M
    Goodwill$1.95M$1.96M$2.03M$2.01M$1.80M$1.89M$1.86M$2.00M$1.97M
    Intangibles$13.12M$11.52M$10.40M$0$0$0
    Total Assets$96.25M$102.50M$113.37M$664.17M$202.95M$435.56M$751.18M$752.18M
    LiabilitiesTotal Current Liabilities$13.77M$19.89M$25.62M$38.78M$20.41M$41.73M$72.99M$103.57M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$422.0K$75.0K$1.69M$2.76M$3.29M$3.45M$17.50M$16.83M
    Total Liabilities$17.39M$23.05M$30.09M$537.51M$125.26M$46.81M$92.32M$122.20M
    EquityCommon Stock & APIC$672.0K$826.0K$980.0K$2.11M$7.02M$7.38M$7.75M$7.93M
    Retained Earnings-$158.25M-$210.95M-$299.55M-$378.33M-$993.26M-$1.21B-$2.29B-$2.70B
    Total Equity$57.59M$78.86M$79.45M$83.28M$126.65M$77.69M$388.75M$658.86M$629.98M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$35.11M-$20.76M-$48.11M-$72.59M-$41.58M-$76.76M-$142.11M-$322.93M-$458.43M
    Cash from Investing-$331.0K-$341.0K-$421.0K-$306.0K-$624.0K-$587.77M-$205.34M-$174.31M-$262.57M
    Cash from Financing$44.51M$49.51M$50.55M$77.92M$620.24M$86.51M$381.23M$617.53M$842.51M
    SummaryCapital Expenditure-$157.0K-$205.0K-$421.0K-$306.0K-$624.0K-$128.0K-$139.0K-$657.0K-$1.39M
    Free Cash Flow-$35.26M-$20.96M-$48.53M-$72.89M-$42.21M-$76.89M-$142.25M-$323.59M-$459.82M
    FCF Margin-61.8%-2821.3%-5643.3%-4029.5%-5986.7%

    Ratios